Chymotrypsin

DRUG3 trials

Sponsors

B.P. Koirala Institute of Health Sciences, Shanghai Bao Pharmaceuticals Co., Ltd., Fayoum University

Conditions

BurnBurn Wounds - Partial Thickness (2nd Degree)Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin Chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar SurgeryIrreversible Pulpitis (Toothache)

Phase 2

Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns

RecruitingNCT07025408

Shanghai Bao Pharmaceuticals Co., Ltd.Burn, Burn Wounds - Partial Thickness (2nd Degree)

Start: 2025-06-16End: 2026-08-29Target: 144Updated: 2025-06-17

Phase 4

Comparative Evaluation of Intraligamentary Injection of Dexamethasone, Diclofenac Sodium, and Chymotrypsin for Enhancing the Success of 4% Articaine Buccal Infiltration in Mandibular Molars With Symptomatic Irreversible Pulpitis

CompletedNCT07506265

Fayoum UniversityIrreversible Pulpitis (Toothache)

Start: 2025-05-23End: 2026-01-01Updated: 2026-04-06

Unknown Phase

Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery

RecruitingNCT06713733

B.P. Koirala Institute of Health SciencesClinical Efficacy of Submucosal Dexamethasone and Oral Trypsin Chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery

Start: 2024-09-25End: 2025-01-25Target: 50Updated: 2024-12-03